Canadian Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Vaxil Bio

Market Cap: CA$1.4m

A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.

Onco-Innovations

Market Cap: CA$80.8m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

High Tide

Market Cap: CA$226.6m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Entheon Biomedical

Market Cap: CA$1.8m

Operates as a biotechnology research and development company.

Crescita Therapeutics

Market Cap: CA$10.1m

A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.

Cronos Group

Market Cap: CA$929.5m

Operates as a cannabinoid company that engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

BioSyent

Market Cap: CA$116.7m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Medicenna Therapeutics

Market Cap: CA$70.4m

An immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases.

Psyence Group

Market Cap: CA$2.1m

A life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom.

Innovotech

Market Cap: CA$7.0m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Devonian Health Group

Market Cap: CA$26.7m

Engages in the development of botanical drugs.

Knight Therapeutics

Market Cap: CA$556.4m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Grown Rogue International

Market Cap: CA$118.2m

A craft cannabis company, focuses on premium flower and flower-derived products.

Bright Minds Biosciences

Market Cap: CA$283.2m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

1CM

Market Cap: CA$38.9m

Operates as a multi-jurisdictional cannabis company in Canada.

Microbix Biosystems

Market Cap: CA$50.2m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Captor Capital

Market Cap: CA$2.0m

Engages in the retail sale of cannabis products in the United States.

Steep Hill

Market Cap: CA$970.7k

Does not have significant operations.

Oncolytics Biotech

Market Cap: CA$60.5m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

Covalon Technologies

Market Cap: CA$64.2m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

Rubicon Organics

Market Cap: CA$26.7m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada.

MediPharm Labs

Market Cap: CA$35.3m

A pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

NurExone Biologic

Market Cap: CA$53.8m

Operates as a pharmaceutical technology company.

Rize Oncology

Market Cap: CA$4.5m

A pharmaceutical company, develops oncology therapies for the treatment of soft tissue sarcoma.

Telo Genomics

Market Cap: CA$9.0m

A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.

InnoCan Pharma

Market Cap: CA$55.3m

A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.

Satellos Bioscience

Market Cap: CA$104.5m

A biotechnology company, develops regenerative therapeutics to treat degenerative muscle diseases primarily in Canada and Australia.

Eupraxia Pharmaceuticals

Market Cap: CA$148.4m

A clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector.

Blueberries Medical

Market Cap: CA$7.4m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

ME Therapeutics Holdings

Market Cap: CA$266.3m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

BriaCell Therapeutics

Market Cap: CA$22.3m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

Aurora Cannabis

Market Cap: CA$325.5m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Avant Brands

Market Cap: CA$11.4m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

Thiogenesis Therapeutics

Market Cap: CA$25.5m

A biopharmaceutical company, develops thiol-active therapeutic compounds to treat unmet pediatric medical needs.

COSCIENS Biopharma

Market Cap: CA$12.6m

A specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally.

Voyageur Pharmaceuticals

Market Cap: CA$30.5m

Engages in the acquiring, exploring, and developing raw materials for pharmaceutical products in the province of British Columbia, Canada, and the state of Utah.